Učitavanje...
Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
“In clinical practice, it is common for warfarin to be initiated at a fixed dose for the first several doses.”
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110075/ https://ncbi.nlm.nih.gov/pubmed/24897277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.14.18 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|